Exotech Bio Solutions

Biodegradable Superabsorbent Polymers

Health Tech & Life Sciences
Acquired (Inactive) by PolyGreen on Jan 2016 - closed due to acquisition
Follow

Company Overview

Snapshot

Founded in December 1999, Exotech Bio Solutions operates with 1–10 employees. The company raised $5 million across one funding round. Exotech Bio Solutions was acquired by PolyGreen in January 2016.

Business overview

Exotech Bio Solutions is a chemical company based in Israel that specializes in developing biodegradable and superabsorbent polymers. Its core technology, the ethylene-bis-stearamide (EBS) compound, is designed to biodegrade completely within two months. The company's products are applicable across various markets, including personal hygiene, agriculture, and nursing, with potential uses in items such as biodegradable diapers and diet pills. Exotech Bio Solutions operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.

Strategic signal

In September 2016, news highlighted Exotech Bio Solutions' breakthrough in biodegradable polymers, specifically its potential to pave the way for 'green' diapers. This signals the company's innovative impact on sustainable product development within the consumer goods and healthcare sectors, demonstrating the commercial viability of its environmentally friendly material science.

Log in to access full profile

Company Intelligence Q&A

What is Exotech Bio Solutions' primary focus?
Exotech Bio Solutions primarily focuses on developing biodegradable and superabsorbent polymers for applications in personal hygiene, agriculture, and nursing.
When was Exotech Bio Solutions founded?
Exotech Bio Solutions was founded in December 1999.
What is the key innovation developed by Exotech Bio Solutions?
Exotech Bio Solutions' key innovation is the ethylene-bis-stearamide (EBS) compound, a biodegradable polymer designed to degrade completely within two months.
How much capital did Exotech Bio Solutions raise?
Exotech Bio Solutions raised $5 million across one funding round in April 2006.
Log in to access full profile